Expertise in
7
conditions

Peter Hohenberger

Mannheim, BW, DE 
Expertise in
7
conditions
Mannheim, BW, DE 

Overview

Peter Hohenberger practices practicing medicine in Mannheim, Germany.

Mr. Hohenberger is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Gastrointestinal Stromal Tumor, Adult Soft Tissue Sarcoma, Desmoid Tumor, Pancreaticoduodenectomy, and Tissue Biopsy.

He is actively involved in clinical research, co-authoring 216 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Mannheim, BW 68135, Germany
Other Locations
Div. Of Surgical Oncology, Heidelberg, BW, Germany
BG Trauma Center Ludwigshafen, Ludwigshafen Am Rhein, RP 67071, Germany
Salem, BW, Germany
Charité Universitaetsmedizin BerlinCampus
Berlin, BE, Germany
Karlsruhe, BW 76021, Germany
Bad Saarow, BB, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase III Randomized Study of Preoperative Radiotherapy Plus Surgery Versus Surgery Alone for Patients With Retroperitoneal Sarcoma (RPS)
A Phase III Randomized Study of Preoperative Radiotherapy Plus Surgery Versus Surgery Alone for Patients With Retroperitoneal Sarcoma (RPS)
Enrollment Status: Completed
Publish Date: April 24, 2023
Intervention Type: Procedure, Radiation
Study Phase: Not Applicable
An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)
An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)
Enrollment Status: Completed
Publish Date: October 06, 2022
Intervention Type: Drug
Study Drugs: Avapritinib, Regorafenib
Study Phase: Phase 3
Optimized Response Assessment of Gastrointestinal Stromal Tumors Using Dual-Energy CT: Prospective Multicenter-Multinational Trial in Patients Undergoing Targeted Therapy With a TKI Inhibitor.
Optimized Response Assessment of Gastrointestinal Stromal Tumors Using Dual-Energy CT: Prospective Multicenter-Multinational Trial in Patients Undergoing Targeted Therapy With a TKI Inhibitor.
Enrollment Status: Completed
Publish Date: April 07, 2022
Intervention Type: Diagnostic test
Single-arm, Multicenter, Open Label Phase II Trial to Evaluate the Efficacy of Pazopanib in Combination With Paclitaxel in Advanced and Relapsed Angiosarcoma
Single-arm, Multicenter, Open Label Phase II Trial to Evaluate the Efficacy of Pazopanib in Combination With Paclitaxel in Advanced and Relapsed Angiosarcoma
Enrollment Status: Terminated
Publish Date: March 22, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Phase II Window-of-opportunity Study of Preoperative Therapy With Pazopanib (Votrient®) in High-risk Soft Tissue Sarcoma
A Phase II Window-of-opportunity Study of Preoperative Therapy With Pazopanib (Votrient®) in High-risk Soft Tissue Sarcoma
Enrollment Status: Terminated
Publish Date: January 26, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

216 Total Publications

Selective Internal Radiation Therapy (SIRT) for SDH-Deficient GIST Demonstrates Encouraging Durable Response Rates: An International Multicenter Case Series.
Selective Internal Radiation Therapy (SIRT) for SDH-Deficient GIST Demonstrates Encouraging Durable Response Rates: An International Multicenter Case Series.
Journal: Cancers
Published: July 09, 2026

Frequently Asked Questions about Peter Hohenberger

Is Peter Hohenberger a top-rated expert for Gastrointestinal Stromal Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Peter Hohenberger is classified as an Elite expert for Gastrointestinal Stromal Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Peter Hohenberger participate in research or clinical trials?

Yes. Peter Hohenberger has published 216 articles and abstracts on conditions like Gastrointestinal Stromal Tumor. You can view a list of Peter Hohenberger's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hohenberger's expertise for a condition
ConditionClose
View All 24 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile